To kick off the new year, Visikol announced it expanded its footprint in New Jersey by moving its headquarters to a 6,400-square-foot space in Hampton, with room to grow.
The new facility will be in the Perryville III building – a 288,000-square-foot class A office building off Interstate 78.
What started off as a university spin-out from Rutgers University almost four years ago, Visikol has been rapidly growing ever since. Currently, it has almost five dozen pharmaceutical companies that are leveraging its digital pathology, advanced imaging and 3-D cell culture assays to accelerate drug discovery and development programs.
To accommodate a growing client list and a breadth of assay services, Visikol needed to expand its footprint and in the process has made substantial improvements to its laboratory facility through its move to the Perryville site. The space is split evenly between office space and lab space to house the sixteen-person Visikol team and its various service offerings. Within the space, Visikol has dedicated spaces for advanced imaging, computing, cell culture, histopathology and general laboratory work.
“Initially, when we launched the company we decided to stay in New Jersey and build the company out of the NJEDA CCIT [New Jersey Economic Development Authority Commercialization Center for Innovative Technologies] incubator simply out of convenience as it was a few hundred feet away from our labs at Rutgers. However, as we have grown, we have really enjoyed building our business in New Jersey and have found it to be a great location for being close enough to clients but also affordable wherein we can provide our clients best-in-class services at an attractive price point,” said Visikol Chief Executive Officer Dr. Michael Johnson.
Over the next few years, Visikol will use this new facility as a springboard to expand its services through continual R&D as well as to execute client projects through the companies current service offering.